BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6234897)

  • 21. Increased helper inducer and decreased suppressor inducer phenotypes in the rheumatoid joint.
    Lasky HP; Bauer K; Pope RM
    Arthritis Rheum; 1988 Jan; 31(1):52-9. PubMed ID: 2964240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of lymphocytes from rheumatoid arthritis patients by mitogens and IgG.
    Sany J; Clot J
    Allerg Immunol (Leipz); 1976; 22(2):147-58. PubMed ID: 136882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased concanavalin A-binding capacity of immunoglobulin G purified from sera of patients with rheumatoid arthritis.
    Malaise MG; Franchimont P; Bouillene C; Houssier C; Mahieu PR
    Clin Exp Immunol; 1987 Jun; 68(3):543-51. PubMed ID: 3652523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rheumatoid factors and HLA-DR4 in RA.
    Emery P; Panayi GS; Welsh KI; Cole BC
    J Rheumatol; 1985 Apr; 12(2):217-22. PubMed ID: 3875716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.
    Lau CS; McLaren M; Hanslip J; Kerr M; Belch JJ
    Ann Rheum Dis; 1993 Sep; 52(9):643-9. PubMed ID: 8239758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppressor cell activity in patients with rheumatoid arthritis.
    Smolen JS; Lanzer G; Scherak O; Menzel EJ; Steffen C; Knapp W
    Agents Actions Suppl; 1980; 7():204-7. PubMed ID: 6454336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rheumatoid factor and serum IgG, IgM and IgA levels in rheumatoid arthritis with vasculitis.
    Veys EM; Gabriel PA; Coigne E; Mielants H
    Scand J Rheumatol; 1976; 5(1):1-6. PubMed ID: 1257704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressor T cell dysfunction and anti-suppressor cell antibody in active early rheumatoid arthritis.
    Abdou NI; Lindsley HB; Racela LS; Pascual E; Hassanein KM
    J Rheumatol; 1981; 8(1):9-18. PubMed ID: 6452523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of immunoregulatory T lymphocytes during ageing by monoclonal antibodies.
    Mascart-Lemone F; Delespesse G; Servais G; Kunstler M
    Clin Exp Immunol; 1982 Apr; 48(1):148-54. PubMed ID: 6211314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis.
    Fox RI; Fong S; Sabharwal N; Carstens SA; Kung PC; Vaughan JH
    J Immunol; 1982 Jan; 128(1):351-4. PubMed ID: 6976376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helper T cell function of rheumatoid synovial tissue lymphocytes.
    McCain GA
    J Rheumatol; 1984 Aug; 11(4):438-47. PubMed ID: 6237204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B cell activation by pokeweed mitogen in cultures of normal peripheral blood lymphocytes depleted of T regulator subsets by treatment with OKT4 and OKT8 monoclonal antibodies.
    Jones BM
    Clin Exp Immunol; 1983 Mar; 51(3):461-9. PubMed ID: 6221842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis.
    Coremans IE; Hagen EC; Daha MR; van der Woude FJ; van der Voort EA; Kleijburg-van der Keur C; Breedveld FC
    Arthritis Rheum; 1992 Dec; 35(12):1466-75. PubMed ID: 1282009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis.
    Heurkens AH; Hiemstra PS; Lafeber GJ; Daha MR; Breedveld FC
    Clin Exp Immunol; 1989 Oct; 78(1):7-12. PubMed ID: 2805426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of atomic bomb radiation on the differentiation of B lymphocytes and on the function of concanavalin A-induced suppressor T lymphocytes.
    Yamada Y; Neriishi S; Ishimaru T; Shimba N; Hamilton HB; Ohgushi Y; Koyanagi M; Ichimaru M
    Radiat Res; 1985 Feb; 101(2):351-5. PubMed ID: 3156391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases.
    Morimoto C; Romain PL; Fox DA; Anderson P; DiMaggio M; Levine H; Schlossman SF
    Am J Med; 1988 May; 84(5):817-25. PubMed ID: 2966579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired proliferative response to concanavalin A in patients with rheumatoid arthritis: a consequence of drug-induced T-lymphocyte damage.
    Vogt P; Tamm M; Hügli S; Müller W
    Clin Exp Rheumatol; 1986; 4(4):307-12. PubMed ID: 3491714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitogens of B and T cells from peripheral blood in rheumatoid arthritis.
    Clot J; Mathieu O; Sany J; Serre H
    Rheumatology; 1975; 6():199-208. PubMed ID: 1081725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications.
    Geirsson AJ; Sturfelt G; Truedsson L
    Ann Rheum Dis; 1987 Oct; 46(10):727-33. PubMed ID: 3689000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired suppressor cell activity due to surface sulphydryl oxidation in rheumatoid arthritis.
    Brown-Galatola CH; Hall ND
    Br J Rheumatol; 1992 Sep; 31(9):599-603. PubMed ID: 1388084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.